Background. Sigma H (sigH) is a major Mycobacterium tuberculosis (Mtb) stress response factor. It is induced in response to heat, oxidative stress, cell wall damage, and hypoxia. Infection of macrophages with the D-sigH mutant generates more potent innate immune response than does infection with Mtb. The mutant is attenuated for pathology in mice.
Tuberculosis is responsible for the deaths of .1.7 million people annually [1] . This situation is exacerbated by the emergence of drug-resistant Mycobacterium tuberculosis (Mtb) [2, 3] , AIDS coinfection [4] , and the failure of the BCG vaccine [5] . Development of efficacious treatments and vaccines against tuberculosis will require better understanding of the pathogenesis of Mtb.
Alternative sigma (r) factors allow bacteria to respond to changes in the extracellular environment by modulating the expression of specific sets of genes [6] . The temporal expression of specific regulons controlled by the induction of $1 of the 10 alternate r factors [7] encoded by its genome may allow Mtb to survive in diverse environments encountered by it in vivo. Sigma H (sigH) is an alternate r factor induced by various stress conditions, phagocytosis, cell wall damage, enduring hypoxia, and reaeration and possibly plays a role in reactivation [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] . The D-sigH mutant fails to induce granulomatous pathology in spite of bacterial replication in mice [8] . Infection of nonhuman primate (NHP) bone-marrow macrophages with Mtb:D-sigH results in a significantly enhanced monocyte chemotaxis and apoptosis relative to cells infected with Mtb [20] . Thus, sigH appears to code for functions crucial for modulating immune response.
Due to their physiological and immunological similarity to humans, NHPs are excellent experimental models of tuberculosis [21, 22] . Two key NHP models of tuberculosis exist. One model is based on infected cynomolgus macaques with virulent Mtb via the intratracheal route [22] . The other model is based on infection of rhesus macaques with virulent Mtb via the aerosol route mimicking the natural method of exposure [23] [24] [25] . By modulating the number of infectious aerosols presented, it is possible to model either acute [23, 24] or latent [25] tuberculosis in these NHPs. The number of presented aerosols is standardized by plethsymography immediately prior to infection. The acute model is used to understand bacterial pathogenesis, whereas the latent model is used to study the various mediators of latency, reactivation, and tuberculosis/AIDS coinfection [25] . We employed the acute model to address whether sigH is important for growth and replication of Mtb as well as immunopathology in primates.
MATERIALS AND METHODS

Animals and Infection
Animals were cared for according to the National Institutes of Health (NIH) Guide for the Care and Use of Laboratory Animals and Institutional Animal Care and Use Committee guidelines. Aerosol infection of 13 Indian-origin rhesus macaques (Table 1) was performed as described elsewhere [23, 25] . Seven animals were exposed to a high-dose (approximately 5000 colony-forming units [CFUs]) of Mtb CDC1551. Six NHPs were similarly exposed to the Mtb:D-sigH mutant. Blood, bronchoalveolar lavage (BAL), and peripheral lymph node (LN) samples were collected periodically. Clinical assessment of disease, C-reactive protein (CRP) assay, chest radiography (CXR), tuberculin skin test (TST), necropsy, and histopathology procedures, including the analysis of percentage of the lung area involved in tuberculosis-like pathology, have been described in NHPs [23, 25, 26] .
Bacterial Burden
Viable CFUs were compared in periodic BAL fluid and LN homogenates as well as random lung section homogenates at necropsy as described elsewhere [23, 25] , to measure the burden of viable tubercle bacilli. For confocal microscopy based detection of the bacilli in the lung lesions, a polyclonal anti-Mtb antibody raised in rabbit (Abcam ab905) was used as described elsewhere [23] [24] [25] [26] .
Comparison of Granulomatous Gene-Expression Upon Infection With Mtb and Mtb :D-sigH DNA microarray experiments were performed as described elsewhere [24] . Transcripts isolated from 3 randomly chosen NHPs from each group were profiled, relative to normal rhesus lung tissue. 
, and CD25
1 cells in tissues were counted by immunohistochemistry as described elsewhere [27] . The following Abbreviations: N, negative; NC, not conducted; NNN, a negative TST was recorded at each of the 3 time points (24, 48 , and 72 hours); NPP, a positive TST was recorded at the 48-and 72-hour time points only; P, positive; PPP, a positive TST at each of the 3 time points; TST, tuberculin skin test. a PRIMAGAM, an interferon c release assay, was substituted for TST [33] .
antibodies were used: anti-CD3 (Dako-A0452, rabbit, 1:50); antiFoxP3 (Vector Labs-VP-C340, mouse, 1:50) and anti-CD25 (eBioscience-14-4776-82, rat, 1:50). Multilabel confocal immunofluorescence was performed using previously described protocols [23] [24] [25] [26] that used the following antibodies: interferon c (IFN-c) (1:10, mouse, BD Biosciences 551221); CD3 (1:10; mouse, Dako M7254), and FoxP3 (1:500; rabbit, Abcam ab10901).
Recruitment of Monocytes Derived From Bone Marrow Upon Infection
In vivo bromodeoxyuridine (BrdU) pulse-labeling and flowcytometric analysis were performed as described elsewhere [28] . In total, 6 of 7 NHPs in this group had elevated temperatures of .2°F higher than average preinfection temperatures at the week 3 postinfection time point, whereas none of the 6 NHPs exposed to Mtb:D-sigH experienced a significant increase in body temperature at any time during the study ( Figure 1A ). The Mtb-infected NHPs exhibited significant weight loss over the study period, losing 5%-25% of their body weight over the duration of the study ( Figure 1B ). In fact, by week 7 postinfection, the NHPs in this group had lost an average of approximately 12% in body weight. In contrast, the NHPs in the mutant-infected group gained an average of 7% body weight during the study ( Figure 1B ).
RESULTS
Comparison of Clinical Correlates of Infection in NHPs Infected
NHPs infected with Mtb are known to exhibit increased serum levels of acute-phase proteins such as CRP. We therefore studied serum levels of CRP to measure systemic inflammation, over the course of infection [23, [25] [26] [27] . The serum CRP levels spiked in each of the 7 Mtb-infected NHPs between 3 and 6 weeks postinfection ( Figure 1C ) and were significantly elevated relative to preinfection baseline for each of the 7 NHPs ( Figure 1C ). At week 3 postinfection, the CRP values for the NHPs in this group ranged from 3.26 to 44.75 mg/L, as compared with preinfection values ranging from 0.0 to 0.4 mg/L. The mutant-infected NHPs did not exhibit elevated CRP values. The maximal CRP value for the mutant-infected NHPs throughout the study was 2.5 mg/L. Only 2 animals in this group exhibited higher than baseline CRP values at any time point but with significantly lower magnitude. The differences between the 2 groups were significant from week 3 postinfection onward ( Figure 1C ).
CXRs from these NHPs were assigned a subjective score on a scale of 0-3, using the following scoring criterion: no involvement, 0; minimal disease, 1; moderate disease, 2; and severe/miliary disease, 3 [23, 25] . All NHPs infected with Mtb exhibited gradually increasing CXR scores that were significantly higher than baseline scores at weeks 3 and 7 postinfection. The mutant infected animals indicated significantly lower CXR scores ( Figure 1D ). These results corroborate the lack of progression of tuberculosis in NHPs infected with Mtb:D-sigH, relative to NHPs infected with Mtb, in this high-dose, acute disease model.
Survival Differences Between the 2 Groups of NHPs
Differences in the progression of tuberculosis in NHPs infected with Mtb vs Mtb:D-sigH were apparent in the survival of the 2 groups. All 7 NHPs infected with Mtb succumbed to acute, pulmonary tuberculosis within 13 weeks postinfection. The median time to death for this group was 65 days ( Figure 1E ). None of the animals infected with the mutant died during this period due to disease. These NHPs were experimentally killed. The survival proportions between the 2 groups were statistically significant ( Figure 1E ).
Bacterial Burden in NHPs Infected With Mtb and Mtb :D-sigH
We analyzed bacterial burden in BAL temporally at 3, 5, 9, and 11 week postinfection. A gradual increase in the number of viable Mtb CFUs was observed. In NHPs exposed to Mtb, viable CFU load was detected beginning week 5 postinfection, peaking at week 9 postinfection (average, 2 3 10 3 CFUs).
No viable CFUs could be detected in the BAL fluid obtained from mutant-infected NHPs 5 week postinfection. Significantly low numbers of CFUs were recovered in the BALs of some NHPs in this group (1-2 3 10 2 CFU) relative to the Mtb group at weeks 9 and 11 ( Figure 2A) . Similarly, significantly high bacillary load was observed in the LNs of Mtb-infected NHPs, relative to mutant-infected NHPs. A higher load was observed for both groups at week 9 postinfection, relative to week 3 postinfection. The levels of Mtb:D-sigH in LNs were significantly lower relative to Mtb throughout the study ( Figure 2B ).
Finally, we assessed the Mtb load in lungs at the time of necropsy ( Figure 2C ). Average lung CFU values in Mtb-infected NHPs ranged from 7 3 10 3 to 8 3 10 4 CFUs/g. In contrast, the average lung CFUs in the mutant-infected NHPs were significantly lower, ranging from 0 to 3.3 3 10 2 CFUs/g ( Figure 2C ).
The Mtb:D-sigH mutant exhibits a remarkably reduced bacterial burden in tissues compared with Mtb, in the NHP model. The CFU results from BAL and lung were corroborated by immunofluorescence-based detection of bacilli in the lungs of Mtb-( Figure 2D ) and mutant-infected NHPs ( Figure 2E ). Significantly higher levels of bacterial infection could be observed in the lungs of NHPs infected with Mtb ( Figure 2D ), whereas lungs of NHPs infected with the mutant were largely devoid of any bacilli ( Figure 2E ). The NHPs infected with Mtb exhibited extensive pulmonary granulomatous immunopathology. The observed disease pathology was similar to an earlier study in which NHPs were exposed to a high dose of Mtb transposon mutants [23] . The extent of diseased tissue involved in tuberculous lesions (necrosis, granulomas, edema, etc) was calculated as a percentage of the total area (Figure 3) . The average percentage of involvement in the lungs of Mtb and Mtb:D-sigH infected NHPs were 56.6% and 8.6%, respectively. Significant differences were apparent in lung lesions of the 2 groups ( Figure 3A) . Although the lungs of NHPs infected with high-dose Mtb exhibited multifocal and confluent graulomas (Figure 3B ), the animals infected with the mutant exhibited relatively few and widely scattered lesions ( Figure 3B ). Histopathologic analysis using hematoxylin and eosin-stained lung tissues confirmed that the lesions observed in the NHPs infected with both Mtb and Mtb:D-sigH exhibited classical tuberculoid pattern with central necrosis and a peripheral infiltrate consisting of histiocytes, lymphocytes, and multinucleated giant cells ( Figure 3C ). NHPs infected with Mtb also exhibited acute inflammation with hemorrhage and neutrophilic infiltration suggesting concurrent chronic and rapid progression. Therefore, the infection with a high dose of Mtb:D-sigH produced a significantly and severely blunted tuberculosis disease.
Granulomatous Immune Response to Infection of NHPs With
Mtb :D-sigH, Relative to Mtb Using global transcriptomics, lung tubercular lesions from the 2 groups of NHPs were used to study changes in the pattern of immune response to infection [24] . Because we have already reported the transcriptome of primate lesions in response to Mtb infection at both the acute and the chronic stages [24] , here we focused on genes that exhibit maximal significance in the magnitude of gene expression between the 2 groups, using multiple-hypothesis corrected P value ( Figure 4A ).
The expression of MMP9 (150-fold), CCL5 (28-fold), LTA (10-fold), and FOSB (4-fold) genes was induced to significantly higher levels in the lesions of Mtb-infected NHPs but remained at normal levels in lesions from the mutant-infected NHPs ( Figure 4A ). On the other hand, the expression of SOCS3 (8-fold), FOXJ1 (6-fold), BAX (5-fold), and CCL14 (3-fold) was induced to significantly higher levels in the lesions of mutant-infected NHPs, relative to Mtb-infected NHPs.
Because the expression of several proinflammatory genes was induced to higher levels in Mtb lesions, we studied the expression of the prototypical proinflammatory molecule, IFN-c, by immunofluorescence. Lesions derived from Mtbinfected NHPs exhibited significantly high IFN-c levels ( Figure 4B ), relative to lesions from mutant-infected NHPs ( Figure 4C ). We also studied the expression of the regulatory T cell (Treg) marker FoxP3 on T cells in these lesions by immunohistochemistry ( Figure 5A -C) and immunofluorescence ( Figure 5D and 5E). The total number of (CD3 1 ) T cells was significantly higher in the mutant lesions, relative to Mtb lesions ( Figure 5A and 5E ). This result is consistent with the fact that animals in the Mtb group exhibited acute pathology. However, the percentage of T cells that also exhibited FoxP3 expression was slightly higher in the mutant group, Figure 3 . Postnecropsy pathology data from the 2 groups of nonhuman primates (NHPs). The percentage of lung area with tuberculosis-related pathology was estimated in both groups of NHPs (A ) using methods described elsewhere [23, 25] . although this difference was not significant (Figure 5B and 5F). The mutant-derived lesions also showed slightly higher number of T cells positive for CD25, an activation marker typically expressed on Tregs, but this difference was also not significant ( Figure 5C ).
Recruitment of Monocytes Derived From Bone Marrow During Infection With Mtb and Mtb:D-sigH
We compared the dynamic recruitment of monocytes in response to infection with Mtb, relative to infection with the mutant, in the 2 groups of NHPs at different stages of infection by in vivo BrdU labeling and flow cytometry. BrdU was injected 24 hours prior to bleeds [28] . Four animals in each group were used for these assays. No differences in BrdU incorporation was observed in the 2 groups preinfection ( Figure 6A) . However, at 4-5 weeks postinfection, the level of BrdU 1 monocytes was significantly higher in the blood of Mtb-infected NHPs, relative to the mutant-infected group ( Figure 6B ). Only 2 NHPs in the mutant group exhibited an increase in the incorporation of BrdU in CD14 1 over . Eukaryotic cells were detected using a nuclear stain (TO-PRO3) (blue signal ), and Mtb was detected using an Mtb-specific antibody (red signal ), both as described elsewhere [23] [24] [25] [26] . IFN-c was detected using a specific antibody (green signal ) as described in the ''Materials and Methods'' section.
baseline values, but the magnitude of this increase was substantially lower than that observed in all 4 NHPs from the Mtb group. These differences were highly significant.
DISCUSSION
The work of several laboratories has established that sigH is a major stress response factor of Mtb [8] [9] [10] that is either directly or indirectly involved in coordinating the pathogen's response to a wide variety of stress conditions [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] . The Mtb:DsigH mutant is attenuated for pathology but not Mtb replication in mice [8] , and more susceptible to a variety of stress conditions [9, 10, 15] . A significantly higher number of Mtb mutants are attenuated in NHPs, compared with murine lungs [23] . We therefore hypothesized that the Mtb:D-sigH mutant may be attenuated for bacterial growth in the NHP model. The Mtb:D-sigH mutant elicits a more robust immune response upon infecting host macrophages, relative to infection with Mtb [20] . This greater immune response is characterized by significantly higher levels of b-chemokine secretion and chemotaxis of naive monocytes, and a higher degree of apoptosis [20] . Similar results have been reported for SigE, a related alternate r factor [29] . It is therefore conceivable that SigH and SigE induce the expression of molecule(s) that interact with and modulate chemotaxis and apoptosis by host macrophages. Conceivably, this would aid Mtb in its persistence and dissemination of the initial infection, because chemotaxis is necessary for activated immune cells to arrive at the initial site of infection [30] , and apoptosis is a key mechanism for the innate clearance of Mtb [31] . Therefore, we also hypothesize that infection of NHPs with the Mtb:D-sigH mutant will elicit a much stronger immune response than with Mtb alone. This scenario is consistent with the hypothesis that increased SigH and other antioxidative mechanisms are responsible for reduced immunogenicity of the BCG vaccine strains [32, 33] . We have devised experiments to test whether the Mtb:D-sigH mutant is attenuated for both bacterial infection in the NHP model.
Clinical, microbiological, and pathological assays show that the Mtb:D-sigH mutant is attenuated for both bacterial burden and immunopathology. Although NHPs infected with Mtb developed acute tuberculosis and died within weeks, the NHPs infected with the mutant remained completely devoid of disease. Therefore, the Mtb sigH regulon is required for full virulence in primates. Specific mechanisms behind this significant attenuation are presently unclear. It is possible that the rate of intrinsic replication of the mutant is reduced in vivo. On the basis of the known functions of SigH, however, and the fact that Mtb:D-sigH exhibits no effect of the mutation during in vitro growth, this is not the likeliest of possibilities. Alternatively, it is possible that the mutant is relatively more susceptible to host innate immunity. SigH is strongly induced in response to redox stress and phagocytosis and may play a role in countering oxidative burst [8] [9] [10] . It is therefore plausible that the reduced burden of the mutant reflects greater susceptibility to phagocyte oxidative burst. Another possibility is that the Mtb:D-sigH strain is incapable of immunomodulating adverse host responses. Our in vitro results that phagocytes infected with Mtb:D-sigH exhibit higher levels of chemotaxis and apoptosis, raise the possibility that antigen(s) regulated by SigH negatively modulate innate phagocytic immune responses and the loss of SigH in the mutant strain unmasks this effect. The current experimental design is insufficient to differentiate between these possibilities. The use of technologies such as unstable plasmids with finite rate of exclusion will allow us to differentiate between replication rate and bacterial burden in vivo [34] . We are now studying the temporal immune response to infection with these strains to better understand the mechanism of attenuation. We are also trying to identify the bacterial factors involved in potentially modulating phagocyte responses.
The induction of MMP9, which promotes granulomatous pathology [35, 36] , CCL5, involved in chemotaxis, LTA, involved in the control of chronic Mtb infection [37] , and FOSB, known to be induced in a tumor necrosis factordependent manner [38] , is consistent with our current understanding. However, proteins that are relatively more abundant in mutant lesions may be more important in understanding the mechanism of attenuation. The proapoptotic BCL2 family member BAX is involved in cell death induced by cytotoxic T cells [39] . Its increased levels in the mutant lesions may be due to increased cytotoxic lymphocyte activity in the lungs of macaques infected with the mutant. Interestingly, modifications that reduce the production of Mtb antioxidants (eg, sigH or sodA) enhance CD8 T-cell responses [32, 40] . In the future, we will design experiments to specifically address this hypothesis.
Alternatively, the attenuation with Mtb:D-sigH may result from the unmasking of Tregs that reduce overexuberant proinflammatory response. Oxidants are reported to significantly reduce tissue inflammation [41] . We observed that the expression of SOCS3, which targets STATs [42] , and FOXJ1, which modulates inflammatory reactions by interfering with the NFjb pathway [43] , was significantly higher in mutant lesions. Recent reports suggest that in an NHP model of tuberculosis, instead of acute disease, the frequency of Tregs was correlated directly to the ability to control infection in a latent state [44] . Because our expression analysis supported the hypothesis that the attenuation of Mtb:D-sigH may be at least in part from reduced inflammation due to Treg activity, we performed experiments to measure Tregs in the lung lesions of the 2 groups. Not surprisingly, total CD3 1 cells were higher in Mtb lesions. However, slightly higher Figure 6 . In vivo bromodeoxyuridine (BrdU) labeling and flow cytometry. Four animals from each group were injected with BrdU (10 mg/kg body weight) as described elsewhere [28] , prior to infection (A ) and 4-5 weeks postinfection (B ). Blood was collected 24 hours after BrdU inoculation. The percentages of BrdU-positive cells in CD14 1 monocytes were analyzed by flow cytometry as described elsewhere [28] .
Treg numbers were seen in the mutant lesions ( Figure 5) . Moreover, the activation status of Tregs (measured by CD25 staining) was also slightly higher in the mutant group. Interestingly, FoxP3 staining was also observed in the mutant group in CD3 -cells ( Figure 5E ). Although we do not know the identity of these cells at the present time, FoxP3 1 macrophages have been recently reported to play roles in modulating inflammation [45] . These results suggest that active suppression of inflammation may be of benefit to the host. BrdU is a reliable marker for dividing cells. Because blood monocytes are unable to proliferate in circulation, they do not incorporate BrdU. Thus, BrdU-labeled monocytes can be considered to have recently migrated from the bone marrow [28] . In vivo BrdU labeling indicates massive destruction of lung macrophages during active tuberculosis. These results are corroborated by the 150-fold induction of MMP9 levels in these lungs.
When the Mtb:D-sigH mutant was used to infect mice, bacterial burden comparable to Mtb was observed in lungs, in the absence of typical pathology [8] . These results in the NHP model are different. In response to Mtb, NHPs generate highly organized, humanlike granulomatous lesions, unlike mice [46] . It is thus conceivable that anti-Mtb responses (eg, hypoxia, oxidative stress) are more effective at the cellular level in the lungs of NHPs and are able to exert a greater degree of immune pressure on the bacilli. This could potentially explain why a mutant may be completely attenuated in the NHP model but only partially attenuated in the mouse model. In an unrelated study of the survival of hundreds of Mtb transposon mutants in NHP lungs, onethird of the mutants failed to survive in the NHP model [23] . In contrast, only 6%-10% of these mutants failed to survive in mice. Moreover, differences in primate vs murine immune system may account for the differential phenotypes of the SigH mutant in these species. In particular, our observations may directly result from the fact that reactive oxygen species play a greater role in primate immune system relative to the murine immune system where nitric oxide is more important. The importance of nitric oxide in primate tuberculosis is a matter of controversy reviewed by Tufariello et al [47] . It is possible that the loss of SigH regulon renders the mutant more susceptible to oxidants rather than to nitric oxide. We are now studying the early features of the immune response generated during early infection with the mutant and comparing it to the response generated by Mtb. Because the Mtb:D-sigH mutant is completely attenuated in NHPs, if a more robust immune response is observed, then this mutant may emerge as a candidate antitubercular vaccine. Interestingly, vaccination with a mutant in the related protein sigE protects against challenge with Mtb [48] . Financial support. This work was supported by the NIH (RR020159,
